FR941011-2-00119 FR941011-2-00079 Advisory Committee on Medical Uses of Isotopes: Meeting Notice AGENCY: Nuclear Regulatory Commission. ACTION: Notice of meeting. SUMMARY: The U.S. Nuclear Regulatory Commission will convene its next regular meeting of the Advisory Committee on Medical Uses of Isotopes (ACMUI) on November 17 and 18, 1994. Topics of discussion will include: (1) Rulemaking on ``Preparation, Transfer, and Use of Byproduct Material for Medical Use''; (2) status of implementation of the Quality Management rule; (3) progress report on the study of the medical use program by the National Academy of Science; (4) brachytherapy fractionation issues; (5) Abnormal Occurrence Criteria Revisions; (6) rulemaking on ``Release of Patients Containing Radiopharmaceuticals or Permanent Implants, 10 CFR 35.75''; (7) discussion on Advanced Notice of Proposed Rulemaking for 10 CFR Part 35; (8) issues involving misadministrations_follow up of patients, NRC use of consultants; (9) review and approval of the bylaws for the Committee; and (10) report on the Commission briefing held on October 20, 1994. DATES: The meeting will being 8 a.m. on November 17 and 18, 1994. ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, Room T2B3, 11545 Rockville Pike, Rockville, MD. FOR FURTHER INFORMATION CONTACT: Larry W. Camper, Office of Nuclear Material Safety and Safeguards, MS T8F5, U.S. Nuclear Regulatory Commission, Washington, DC 20555, Telephone 301&hyph;415&hyph;7269. Conduct of the Meeting Barry Siegel, M.D. will chair the meeting. Dr. Siegel will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit a reproducible copy to Larry W. Camper (address listed above). Comments must be received by November 10, 1994, in order to ensure consideration at the meeting. The transcript of the meeting will be kept open until November 28, 1994, for inclusion of written comments. 2. Persons who wish to make oral statements should inform Mr. Camper, in writing, by November 3, 1994. Statements must pertain to the topics on the agenda for the meeting. The Chairman will rule on requests to make oral statements. Members of the public will be permitted to make oral statements if time permits. Permission to make oral statements will be based on the order in which requests are received. In general, oral statements will be limited to approximately 5 minutes. Oral statements must be supplemented by detailed written statements, for the record. Rulings on who may speak, the order of presentation, and time allotments may be obtained by calling Mr. Camper, 301&hyph;415&hyph;7269, between 9 a.m. and 5 EST, on November 14, 1994. 3. At the meeting, questions from attendees other than committee members, NRC consultants, and NRC staff will be permitted at the discretion of the Chairman. 4. The transcript, minutes of the meeting, and written comments will be available for inspection, and copying, for a fee, at the NRC Public Document Room, 2120 L Street NW., Lower Level, Washington, DC 20555, on or about December 9, 1994. 5. Seating for the public will be on a first-come, first-served basis. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App.); and the Commission's regulations in Title 10, Code of Federal Regulations , Part 7. Dated: October 4, 1994. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 94&hyph;25033 Filed 10&hyph;7&hyph;94; 8:45 am] BILLING CODE 7590&hyph;01&hyph;M
